4//SEC Filing
McCauley Thomas 4
Accession 0000899243-22-034470
CIK 0001850838other
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 6:40 PM ET
Size
5.6 KB
Accession
0000899243-22-034470
Insider Transaction Report
Form 4
McCauley Thomas
Chief Scientific Officer
Transactions
- Award
Option (Right to Buy)
2022-10-27+55,000→ 55,000 totalExercise: $5.27Exp: 2032-10-26→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The options vest and become exercisable as to 25% of the underlying shares on October 27, 2023 and as to 6.25% of the underlying shares upon the Reporting Person's completion of each three full months of continued service to the Issuer thereafter, such that the option will be fully vested and exercisable on October 27, 2026.
Documents
Issuer
Omega Therapeutics, Inc.
CIK 0001850838
Entity typeother
Related Parties
1- filerCIK 0001858760
Filing Metadata
- Form type
- 4
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 6:40 PM ET
- Size
- 5.6 KB